AMLX- Amylyx Pharmaceuticals, Inc.

Name: Amylyx Pharmaceuticals, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Amylyx Pharmaceuticals, Inc. (AMLX) has 7 insiders with recent SEC Form 4 filings, including 1 buy and 17 sells. AMLX is classified in the Pharmaceuticals industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Cohen Joshua B	3.32M	$51.99M	-
CEO	Klee Justin B.	3.32M	$51.99M	-
Dir	Milne George M Jr	812.9K	$12.74M	-
CFO	Frates James M	177.1K	$2.78M	-
Other	Bedrosian Camille L	175.8K	$2.75M	-

Activity

Buys and sells only

Transactions

10 filings · page 6

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Mar 29, 2023	Morningside Venture Investments Ltd93	10% Owner	Sell	29,048	$30.45	$884,511.60	-0.4%	-25.3%	-90.3%
Mar 28, 2023	Morningside Venture Investments Ltd93	10% Owner	Sell	160,964	$30.42	$4,896,561.00	-0.7%	-26.5%	-90.6%
Mar 21, 2023	Morningside Venture Investments Ltd93	10% Owner	Sell	63,448	$31.91	$2,024,494.48	-0.4%	-19.3%	-90.2%
Mar 16, 2023	Morningside Venture Investments Ltd93	10% Owner	Sell	9,122	$32.55	$296,921.10	-0.1%	-22.4%	-89.9%
Mar 16, 2023	Klee Justin B.60	Co-chief Executive Officer	Sell	100,000	$31.86	$3,186,236.20	-1.8%	-22.4%	-89.9%
Mar 16, 2023	Yeramian Patrick D84	Chief Medical Officer	Sell	54,627	$31.87	$1,741,200.40	-15.3%	-22.4%	-89.9%
Mar 16, 2023	Cohen Joshua B60	Co-chief Executive Officer	Sell	100,000	$31.86	$3,186,335.98	-1.8%	-22.4%	-89.9%
Mar 16, 2023	Frates James M83	Chief Financial Officer	Sell	32,500	$31.89	$1,036,459.19	-87.3%	-22.4%	-89.9%
Mar 16, 2023	Milne George M Jr59	Director	Sell	35,000	$31.89	$1,116,072.45	-2.0%	-22.4%	-89.9%
Mar 16, 2023	Firestone Karen	Director	Buy	1,000	$31.99	$31,990.00	New	-22.4%	-89.9%

← PrevPage 6Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC